Bausch & Lomb Incorporated Overview
Company Headquarters: New Jersey, US
Founded: 1853
Workforce: 20,000+
Company Working: Bausch & Lomb Incorporated develops, manufactures, and markets eye care products. The company’s products include contact lens and lens care products, such as chemical disinfectants for soft contact lenses, Boston line of products, and prescription pharmaceutical medicines to treat eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye, and retinal diseases, among others.
Moreover, it also offers contract manufacturing services for sterile and non-sterile solutions, suspensions, ointments, gels, creams, nasals, and injectables. It is headquartered in the US and has additional offices in Argentina, Australia, Austria, Belgium, Bulgaria, Brazil, Canada, China, the Czech Republic/Slovakia, Dubai, France, Germany, Greece, and Hong Kong, among others. Bausch & Lomb Incorporated operates as a subsidiary of Bausch Health Companies Inc.
Strategy
Bausch & Lomb Incorporated's goal is to become a leading, focused pharmaceutical business via the development of novel therapeutic platforms and data science. It focuses on improving its commercial effectiveness in order to better meet the needs of its clients. In order to increase its market share, it also concentrates on product approvals, the purchase and divestment of goods or whole companies, and the establishment of strategic alliances and collaborations. Furthermore, Bausch & Lomb Incorporated has focused its resources on important growth brands and launches, developing next-generation initiatives, and investing in technology platforms while being at the forefront of medication development in novel drugs.



